| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.1 |